Cargando…
NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
PURPOSE: Adriamycin is a novel chemotherapeutic agent of great benefit for treating breast cancer. However, adriamycin ‐resistance remains a major obstacle. The vital Glutathione transferase P1 (GSTPi) inhibitor 6‐(7‐nitro‐2,1,3‐benzoxadiazol‐4‐ylthio) hexanol (NBDHEX) has recently shown antitumor a...
Autores principales: | Sha, Huanhuan, Zou, Renrui, Lu, Ya, Gan, Yujie, Ma, Rong, Feng, Jifeng, Chen, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028113/ https://www.ncbi.nlm.nih.gov/pubmed/36266920 http://dx.doi.org/10.1002/cam4.5370 |
Ejemplares similares
-
In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
por: Sha, Huanhuan, et al.
Publicado: (2020) -
Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer
por: Sha, Huanhuan, et al.
Publicado: (2021) -
Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology
por: Gan, Yujie, et al.
Publicado: (2022) -
Expression of glutathione, glutathione peroxidase and glutathione S-transferase pi in canine mammary tumors
por: Leonel, Camila, et al.
Publicado: (2014) -
Glutathione S-transferase π: a potential role in antitumor therapy
por: Dong, Shu-Chen, et al.
Publicado: (2018)